期刊文献+

中药联合抗真菌药物治疗真菌性角膜炎53例 被引量:5

Traditional Chinese Medicine Combined with Antifungal Agents for Treating Fungal Keratitis in 53 Cases
下载PDF
导出
摘要 目的观察中药联合抗真菌药物治疗真菌性角膜炎的临床疗效。方法选取医院诊治的真菌性角膜炎患者106例,按就诊先后顺序将其分为试验组和对照组,各53例。对照组患者采用5%那他霉素滴眼液和0.2%氟康唑滴眼液滴眼治疗,试验组患者在对照组基础上采用玉屏风散合银花土茯苓汤内服和中药熏蒸患眼治疗。治疗15 d后进行疗效、视力、不良反应、痊愈时间等评估。结果试验组的疗效、视力和痊愈时间均明显优于对照组(P<0.05),两组患者不良反应发生情况无显著性差异。结论中西医结合治疗真菌性角膜炎可取得较好疗效,能缩短痊愈时间,值得临床推广。 Objective To observe the clinical effect of traditional Chinese medicine combined with antifungal agents in treating fungal keratitis. Methods Totally 106 patients with fungal keratitis in the hospital were selected and divided into the experimental group and the control group,53 cases each. The control group adopted 5% Natamycin Eye Drops and 0. 2% Fluconazole Eye Drops for treatment, while on this basis the experimental group adopted oral Yupingfeng Powder and Yinhuatufuling Decoction,and traditional Chinese medicine fumigation eye treatment. The curative effect,vision,adverse reactions and cure time after 15 d treatment were evaluat-ed. Results The experimental group was significantly better than the control group in the curative effect,visual acuity and cure time ( P ﹤ 0. 05);the adverse reactions had no statistically significant difference between the two groups. Conclusion The integrated tradi-tional Chinese and Western medicine for treating fungal keratitis can obtain better curative effect,shorten the cure time and deserves to be promoted in clinic.
作者 邓显峰
出处 《中国药业》 CAS 2015年第10期108-109,共2页 China Pharmaceuticals
关键词 真菌性角膜炎 中西医结合疗法 那他霉素滴眼液 氟康唑滴眼液 玉屏风散 fungal keratitis therapy of integrated traditional Chinese and Western medicine Natamycin Eye Drops Fluconazole Eye Drops Yupingfeng Powder
  • 相关文献

参考文献8

二级参考文献52

  • 1钟文贤,谢立信.真菌性角膜炎的药物治疗[J].国际眼科纵览,2006,30(5):332-336. 被引量:16
  • 2杨侠,董晓光,刘爱明,孙士营,谢立信,王身国.两性霉素B缓释系统治疗兔烟曲霉菌眼内炎的药效学实验研究[J].中华眼科杂志,2007,43(6):546-553. 被引量:4
  • 3Xie L, Zhong W, Shi W, et al. Spectrum of fungal keratitis in north China[ J]. Ophthalmology,2006,113:1943 - 1948.
  • 4Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous,and plasma concentration of orally administered voriconazole in humans[J]. Arch Ophthalmol,2004,122(1 ) : 42 -47.
  • 5Lau D, Fedinands M, Leung L, et al. Penetration of voriconazole, 1% , eyedrops into human aqueous humor: a prospective open-label study [ J ]. Arch Ophthalmol,2008,126 ( 3 ) : 3d-3 - 346.
  • 6Vemulakonda GA, Hariprasad SM, Mieler WF, et al. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans[ J]. Arch Ophthalmol,2008,126(1 ) : 18 -22.
  • 7Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature [ J ]. Br J Ophthalmol,2008,92(7) : 871 - 878.
  • 8Kiraz N, Dag I, Yamac M, et al. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods [ J ]. Antimicrob Agents Chemother,2009,53 ( 2 ) : 788 - 790.
  • 9Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis [ J ]. Clin Infect Dis, 2008,47 ( 3 ) : 364 - 371.
  • 10Vorwerk CK,Tuchen S, Streit F,et al. Aqueous humor concentrations of topically administered caspofungin in rabbits [ J ]. Ophthalmic Res, 2009,41 (2) : 102 - 105.

共引文献110

同被引文献38

  • 1董玉萍.角膜溃疡清创联合羊膜覆盖术治疗真菌性角膜炎的临床效果观察[J].今日健康,2016,15(3):134-134. 被引量:1
  • 2初培莲,张丽彩,闫玲.辨证分期治疗真菌性角膜炎32例[J].山东中医杂志,2005,24(8):477-478. 被引量:2
  • 3Xie L, Zhai H, Zhao J, et al. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong province, China [ J ]. Am J Ophthalmol, 2013,8 ( 2 ) :260 - 265.
  • 4Li L, Wang Z, Li R. In vitro evaluation of combination antifungal activ- ity against fusarium species isolated from ocular tissues of keratomycosis patients [ J ]. Am J Ophthalmol, 2008,146 (5) :724 - 728.
  • 5Thiel MA,Zinkernagel AS, Burhenne J, et al. Voriconszole concentra- tion in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis [ J ]. Antimicrob Agents Chemother, 2007,51 ( 1 ) :239 - 244.
  • 6Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans[ J]. Arch Ophthalmol, 2004,122 ( 1 ) :42 - 47.
  • 7Kiraz N, Dag I, Yamac M, et al. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata:comparison of disk diffusion, Etest, and time kill methods [ J ]. Antimicrob Agents Che- mother, 2009,53 ( 2 ) :788 - 790.
  • 8Tu EY. Alternaria keratitis : clinical presentation and resolution with top- ical fluconazole or intrastromal vorieonazole and topical easpofungin [ J ]. Cornea, 2009,28 ( 1 ) : 116 - 119.
  • 9Kumar M, Shukla PK. Use of PCR targeting of intemal transcribed spacer regions and single - stranded conformation polymorphism analysis of se- quence variation in ifferent regions of rRNA genes in fungi for rapid diag- nosis of mycotic keratitis [ J ]. J Clin Mierobiol, 2005,43 (2) :662 - 668.
  • 10何彦,潘志强.真菌性角膜炎的诊治进展[J].中华眼科杂志,2009,45(9):860-864. 被引量:11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部